Virus- and oncogene-free reprogramming method for the production of iPSCs published in the journal Regenerative Medicine

Written by Regenerative Medicine

Regenerative Medicine is delighted to publish open access original research demonstrating the first virus- and oncogene-free induced pluripotent stem cell (iPSC) technology to produce safer pluripotent stem cells from cord blood and peripheral blood. Cellular Engineering Technologies, the John Paul II Medical Research Institute and the University of Iowa (all IA, USA) have announced a new milestone in the field of regenerative medicine involving the creation of safer and non-controversial pluripotent stem cells from cord blood and peripheral blood obtained from donors. The group, led by Alan Moy (from the above institutions), published their research findings in the scientific journal...

To view the full article, please register now for access

It's completely free